FOLH1 and breast cancer: <b>Methods</b>: We analyzed 22 Luminal A, 47 Luminal B, 9 HER2-positive (HER2+), and 23 triple-negative (TN) BC to assess whether PSMA, Ki67 expression, and tumor-infiltrating lymphocytes (TILs) were different in BC subtypes.